<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Intraosseous infusion</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Intraosseous infusion</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Intraosseous infusion</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Catherine E Perron, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anne M Stack, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Allan B Wolfson, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">James F Wiley, II, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 08, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>This topic will discuss intraosseous (IO) infusion in children and adults, including indications, contraindications, and techniques according to device.</p><p>Other forms of venous access are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6385.html" rel="external">"Vascular (venous) access for pediatric resuscitation and other pediatric emergencies"</a> and  <a class="medical medical_review" href="/z/d/html/13824.html" rel="external">"Peripheral venous access in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/13824.html" rel="external">"Peripheral venous access in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/8194.html" rel="external">"Central venous access in adults: General principles"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6315.html" rel="external">"Basic principles of ultrasound-guided venous access"</a>.)</p><p></p><p class="headingAnchor" id="H1532743960"><span class="h1">BACKGROUND</span><span class="headingEndMark"> — </span>Establishment of access to the circulation is a critical component of resuscitation. The preferred venous access site during cardiopulmonary resuscitation (CPR) is the largest, most accessible vein that does not require the interruption of resuscitation. Peripheral venous access is attempted before attempting other forms of vascular access if peripheral veins can be readily seen or palpated. (See  <a class="medical medical_review" href="/z/d/html/6385.html" rel="external">"Vascular (venous) access for pediatric resuscitation and other pediatric emergencies"</a> and  <a class="medical medical_review" href="/z/d/html/13824.html" rel="external">"Peripheral venous access in adults"</a>.)</p><p>Intraosseous (IO) infusion, a technique for vascular access, was described first in 1922 and was widely used for drug administration in children in the 1940s [<a href="#rid1">1-6</a>]. It fell out of favor during the 1950s and 1960s, when disposable intravenous catheters were developed and techniques for insertion improved. In the 1980s, after the publication of numerous clinical reports of its effective use in children and animal models [<a href="#rid7">7-10</a>], the practice of IO infusion increased. Use in adults has also grown, especially in the prehospital setting [<a href="#rid11">11,12</a>]. Today, the procedure is reserved for acute, life-threatening or medically necessary situations when standard venous access methods cannot be rapidly achieved and as the first attempt at vascular access in cardiopulmonary arrest or severe shock in selected patients.</p><p class="headingAnchor" id="H6338267"><span class="h1">ANATOMY</span><span class="headingEndMark"> — </span>Intraosseous (IO) infusion is possible because of the presence of veins that drain the medullary sinuses in the bone marrow of long bones (<a class="graphic graphic_figure graphicRef77643" href="/z/d/graphic/77643.html" rel="external">figure 1</a>) [<a href="#rid13">13</a>]. These veins, supported by the bony matrix, do not collapse in patients with shock or hypovolemia. The following list provides the site and draining vessels for the most commonly used sites:</p><p class="bulletIndent1"><span class="glyph">●</span>Proximal tibia – Popliteal vein</p><p class="bulletIndent1"><span class="glyph">●</span>Femur – Branches of the femoral vein</p><p class="bulletIndent1"><span class="glyph">●</span>Distal tibia (medial malleolus) – Great saphenous vein</p><p class="bulletIndent1"><span class="glyph">●</span>Proximal humerus – Axillary vein</p><p class="bulletIndent1"><span class="glyph">●</span>Manubrium (upper sternum) – Internal mammary and azygos veins</p><p></p><p>The anterior inferior iliac spine, clavicle, and distal radius have also been used successfully for IO vascular access as have bones without medullary cavities, including the calcaneus and radial styloid [<a href="#rid14">14-16</a>].</p><p class="headingAnchor" id="H1240422519"><span class="h1">TRAINING</span><span class="headingEndMark"> — </span>Intraosseous (IO) cannulation is likely to be used by the emergency care provider during resuscitation. The patient’s life may well depend upon the clinician’s ability to secure vascular access. Thus, emergency physicians and others who may need to perform IO cannulation emergently should learn to do so well in advance of the immediate need.</p><p>Training can take place on simulation models, animal bones (eg, chicken or turkey legs), or a cadaver. IO placement is taught as part of the Pediatric Advanced Life Support, Advanced Pediatric Advanced Life Support (PALS), and Advanced Trauma Life Support (ACLS) courses. After training, typically consisting of a one-hour lecture followed by a one-hour hands-on experience, novice users have achieved success rates of 93 to 97 percent for manual and battery-powered IO placement in a variety of simulated settings [<a href="#rid17">17-21</a>].</p><p>High success rates with battery-powered IO placement have also been shown in field and hospital care after such training:</p><p class="bulletIndent1"><span class="glyph">●</span>Paramedics achieved an 87 percent success rate for field IO placement in infants under two years of age [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Military medics achieved a 97 percent success rate for IO cannulation in children and adults during combat situations [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Physicians achieved a 94 percent success rate for IO placement in 95 children treated in an emergency department [<a href="#rid23">23</a>].</p><p></p><p>Retention of IO needle insertion skills may wane between biannual PALS/ACLS recertification [<a href="#rid24">24</a>]. More frequent simulations utilizing on-your-own-time and just-in-time kits or training may be beneficial [<a href="#rid25">25</a>].</p><p class="headingAnchor" id="H3"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>We recommend that infants and children in cardiopulmonary arrest or severe shock who do not have readily available intravenous (IV) access undergo intraosseous (IO) cannulation rather than central venous line placement or surgical venous cutdown.</p><p>For adults in cardiopulmonary arrest or severe shock in whom IV access cannot be established, we suggest IO cannulation pending central venous line placement or surgical venous cutdown. However, among adults who have suffered an out-of-hospital cardiac arrest, IO vascular access may be associated with a lower rate of return of spontaneous circulation and neurologically favorable survival. (See  <a class="medical medical_review" href="/z/d/html/278.html" rel="external">"Advanced cardiac life support (ACLS) in adults", section on 'Alternative methods for medication administration'</a>.)</p><p>IO cannulation may also be appropriate in emergent or urgent situations where reliable venous access cannot be achieved quickly (eg, patients with shock, sepsis, status epilepticus, extensive burns, multiple trauma) or in patients for whom intravascular access is medically necessary and cannot be achieved by other means despite multiple attempts [<a href="#rid26">26</a>]. In awake patients, analgesia is warranted prior to infusion if the patient’s condition permits. (See <a class="local">'Analgesia'</a> below.)</p><p>IO cannulation allows for intravascular access through which diagnostic studies may be obtained, fluid resuscitation may occur, and a wide variety of medications can be rapidly delivered. (See <a class="local">'Diagnostic studies'</a> below and <a class="local">'Drug and fluid administration'</a> below.)</p><p>The American Heart Association and the International Committee on Resuscitation endorse the use of IO access as a safe and effective means of vascular access in critically ill children and adults [<a href="#rid27">27,28</a>]. IO cannulation permits rapid intravascular access in critically ill children and adults as demonstrated by the following reports:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Children</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a trial comparing success rates and time to insertion between IO and peripheral IV access among children requiring fluid resuscitation for severe dehydration in a hospital setting, the IO route was successful within five minutes for 100 percent of patients, as compared with 67 percent success within five minutes for peripheral IV placement [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a retrospective series describing attempts by paramedics to establish peripheral IV access for 300 children (0 to 18 years) in the prehospital setting, IV access was successful in two-thirds of all children and in only 49 percent of a subset of children younger than six years of age [<a href="#rid30">30</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In an observational series describing the use of IO cannulation in patients of all ages in the prehospital setting, the overall success rate was 76 percent, with 85 percent success in children between one and two years of age [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>IO vascular access was achieved in less than one minute for 85 percent of cases in a prospective report evaluating the time to insertion and success rate of IO cannulation in a variety of prehospital settings [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In an observational study of 95 pediatric emergency department patients receiving IO placement with a battery-driven device, successful insertion and infusion were achieved in 94 percent of individuals. Insertion time was 10 seconds or less in 77 percent of the one-attempt successful cases who had time to insertion reported [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adults</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a trial of 182 adults receiving vascular access for cardiac arrest in the prehospital setting, tibial IO placement was associated with a significantly higher frequency of initial vascular access success than peripheral IV placement (91 versus 43 percent, respectively) [<a href="#rid33">33</a>]. Although initial success with humeral IO access was higher than for peripheral IV access (71 versus 49 percent), overall success was not significantly different because of a high rate of IO catheter displacement among patients with humeral IO cannulas. (See <a class="local">'Sites of placement'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A trial of IO needle placement using a battery-powered driver or spring-loaded device in 40 adults receiving prehospital care found that vascular access was successfully achieved on the first attempt in 80 to 90 percent of patients, and within two minutes [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A prospective observational study compared IO cannulation using a battery-operated driver device (EZIO) with internal jugular or subclavian central venous access in 10 adult patients, all of whom received both procedures [<a href="#rid35">35</a>]. IO access was achieved on the first attempt more frequently (90 versus 60 percent) and took significantly less time (2 versus 10 minutes) than central venous access.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a larger, prospective, observational study of 79 adults undergoing central access placement during inpatient medical resuscitations, IO needle insertion had significantly higher first-pass success than central venous catheter placement (90.3 versus 37.5 percent) and shorter placement times (1.2 versus 10.7 min) [<a href="#rid36">36</a>].</p><p></p><p>Taken together, these studies suggest that establishing peripheral IV access often is delayed or unsuccessful during resuscitation of critically ill patients, particularly small children. Furthermore, alternative methods of vascular access such as central venous access by percutaneous or surgical venous cutdown takes much longer and are less likely to be successful than IO placement. Finally, all drugs and fluids that might be delivered through peripheral or central venous lines can also be administered through an IO cannula. (See  <a class="medical medical_review" href="/z/d/html/6385.html" rel="external">"Vascular (venous) access for pediatric resuscitation and other pediatric emergencies", section on 'Central access'</a> and <a class="local">'Drug and fluid administration'</a> below.)</p><p>In adults, difficult or failed peripheral vascular access is also problematic, especially in the prehospital setting. Alternative approaches to IO cannulation such as ultrasound-guided peripheral IV access and central venous access also achieve high success rates but take longer to perform than IO access. (See  <a class="medical medical_review" href="/z/d/html/6315.html" rel="external">"Basic principles of ultrasound-guided venous access"</a> and  <a class="medical medical_review" href="/z/d/html/6315.html" rel="external">"Basic principles of ultrasound-guided venous access", section on 'Dynamic ultrasound techniques'</a>.)</p><p>IO cannulation by manual insertion becomes progressively more difficult as children age because the cortex of bone becomes thicker and the tibial bone marrow cavity becomes smaller [<a href="#rid6">6,37</a>]. The development of devices such as impact-driven devices and battery-operated handheld drivers has made IO cannulation feasible for patients of all ages [<a href="#rid23">23,27,38</a>]. (See <a class="local">'Techniques'</a> below.)</p><p class="headingAnchor" id="H17935746"><span class="h2">Drug and fluid administration</span><span class="headingEndMark"> — </span>Any IV drug or routine resuscitation fluid can be administered safely by the IO route. Examples include <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, <a class="drug drug_general" data-topicid="9384" href="/z/d/drug information/9384.html" rel="external">dopamine</a>, <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">dobutamine</a>, <a class="drug drug_general" data-topicid="9359" href="/z/d/drug information/9359.html" rel="external">adenosine</a>, digitalis, heparin, <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>, <a class="drug drug_general" data-topicid="8983" href="/z/d/drug information/8983.html" rel="external">atropine</a>, <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a>, <a class="drug drug_general" data-topicid="9769" href="/z/d/drug information/9769.html" rel="external">phenytoin</a>, neuromuscular blocking agents, antibiotics, crystalloids, colloids, and blood products [<a href="#rid8">8,10,37,39-44</a>]. Drug and fluid dosing is the same as for IV administration [<a href="#rid26">26,41</a>]. However, for adenosine, the IO route may not be as effective as upper extremity peripheral IV access for the treatment of supraventricular tachycardia in some young infants [<a href="#rid45">45</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drugs</strong> – When medications are given, the IO cannula should be flushed before and after each medication that is administered. Only compatible drugs may be administered simultaneously through an IO needle or catheter. The IO site and extremity should be monitored frequently for infiltration.</p><p></p><p class="bulletIndent1">Limited evidence suggests that the onset of action and serum drug concentration after IO infusion during cardiopulmonary resuscitation (CPR) appear comparable to those achieved after IV administration [<a href="#rid9">9,46,47</a>]. In 10 adults receiving CPR, a microbubble marker of drug delivery to the right and left ventricles was approximately 10 seconds shorter using a humeral IO than a brachial IV, although this may not have a significant impact on clinical outcome [<a href="#rid48">48</a>]. </p><p></p><p class="bulletIndent1">Although not directly applicable to humans, studies in animals suggest that the IO route is as effective as the central intravenous route [<a href="#rid9">9,49,50</a>] and may be superior to the peripheral intravenous route during pediatric cardiac arrest [<a href="#rid9">9</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rapid fluid administration and viscous drugs</strong> – Crystalloid fluids (eg, normal <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a>) for rapid volume expansion and viscous drugs and solutions should be administered under pressure using an infusion pump, pressure bag, or manual injection through a syringe and stopcock. These approaches overcome the resistance of emissary veins that lead from the intramedullary cavity to the general circulation [<a href="#rid51">51</a>]. The IO site and extremity should be monitored frequently for infiltration during rapid fluid administration.</p><p></p><p class="bulletIndent1">Infusion rates equivalent to a 21 gauge peripheral intravenous catheter are typically achieved [<a href="#rid52">52</a>]. As an example, in a prospective observational study in 24 adults receiving emergency treatment and in whom peripheral venous access could not be achieved, mean rates of fluid administration under pressure were 165 mL/min at the tibial site and 153 mL/min at the humeral site [<a href="#rid53">53</a>]. Among patients who had placement of an IO at both sites, the rate of fluid administration was not significantly different. In another study performed in 16 fresh cadavers, mean flow rates achieved during IO infusion rates under high pressure (300 mmHg) was highest at the sternal site [<a href="#rid54">54</a>]. However, this rate (94 mL/min) was lower than what has been described in adult patients receiving fluid therapy [<a href="#rid53">53</a>] and suggests that the cadaveric model may not be directly applicable to the clinical setting.</p><p></p><p class="headingAnchor" id="H17935753"><span class="h2">Diagnostic studies</span><span class="headingEndMark"> — </span>Based upon comparisons of venous blood and bone marrow samples in children with cancer, bone marrow samples initially obtained from an IO line during placement may be used for a variety of diagnostic studies including glucose, hemoglobin, pH, pCO2, serum bicarbonate, sodium, chloride blood urea nitrogen, creatinine, serum drug levels, and cultures (eg, bacterial, viral, or fungal cultures) [<a href="#rid55">55,56</a>]. By contrast, bone marrow values for blood oxygenation, white blood cell count, platelets, potassium, aspartate aminotransferase, alanine aminotransferase, or ionized calcium may not be accurate. Platelet counts are likely to be lower, while white blood cell counts are generally higher than peripheral blood samples. A waste of 2 mL appears to be sufficient before taking an IO sample [<a href="#rid57">57</a>].</p><p>In a study of 28 adult patients, bone marrow aspirates accurately identified blood ABO and Rh type [<a href="#rid58">58</a>]. Thus, bone marrow samples may also be used for type and screen if a standard blood sample is not available.</p><p>A canine model suggests that IO drug administration may alter subsequent laboratory measurements [<a href="#rid59">59</a>]. Thus, most experts do not advise using IO access for diagnostic studies once drugs have been administered.</p><p class="headingAnchor" id="H4"><span class="h1">CONTRAINDICATIONS</span><span class="headingEndMark"> — </span>There are relatively few absolute contraindications to intraosseous (IO) infusions because the technique is primarily indicated in life-threatening emergencies:</p><p class="bulletIndent1"><span class="glyph">●</span>A fractured bone or previously penetrated bone cannot be used because fluids will exit through the fracture or puncture site.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An extremity with vascular interruption, either from trauma or cutdown attempt, is not suitable for IO infusion because the fluid or drugs administered into the bone marrow will leak through the open blood vessel.</p><p></p><p>If possible, IO cannulation should be avoided in the following patients:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with cellulitis, burns, or osteomyelitis involving the cannulation site [<a href="#rid49">49,51</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with osteogenesis imperfecta or osteopetrosis, who have increased bone fragility. However, successful IO cannulation in a child with osteogenesis imperfecta has been described [<a href="#rid49">49</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with right-to-left intracardiac shunts (eg, tetralogy of Fallot, pulmonary atresia), who may be at greater risk for cerebral fat or bone-marrow emboli [<a href="#rid49">49,60,61</a>]. (See <a class="local">'Complications'</a> below.)</p><p></p><p class="headingAnchor" id="H5"><span class="h1">PREPARATION</span><span class="headingEndMark"> — </span>In most instances, intraosseous (IO) cannulation occurs as part of care for a life-threatening emergency. Thus, informed consent is typically implied. In awake patients for whom IO needle placement is necessary, the patient and, in children, the caretaker should receive a detailed explanation of the procedure and provide informed consent. Awake patients should receive local anesthesia prior to IO cannulation attempts. (See  <a class="medical medical_review" href="/z/d/html/6324.html" rel="external">"Subcutaneous infiltration of local anesthetics"</a>.)</p><p class="headingAnchor" id="H17936252"><span class="h2">Equipment</span><span class="headingEndMark"> — </span>The following equipment should be assembled prior to the procedure:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">Chlorhexidine</a>, <a class="drug drug_general" data-topicid="9801" href="/z/d/drug information/9801.html" rel="external">povidone iodine</a> solution or similar antiseptic</p><p class="bulletIndent1"><span class="glyph">●</span>Surgical mask and eye covering for the clinician performing the procedure</p><p class="bulletIndent1"><span class="glyph">●</span>Sterile latex-free gloves</p><p class="bulletIndent1"><span class="glyph">●</span>10 mL syringe</p><p class="bulletIndent1"><span class="glyph">●</span>Syringe with <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> flush</p><p class="bulletIndent1"><span class="glyph">●</span>IO needle and/or device</p><p class="bulletIndent1"><span class="glyph">●</span>In awake patients, small-volume syringe (eg, 3 mL) containing <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> 1 percent for infiltration via a small bore needle (eg, 25 gauge needle)</p><p></p><p class="headingAnchor" id="H17936215"><span class="h3">Intraosseous (IO) needles and devices</span><span class="headingEndMark"> — </span>Commercially available intraosseous cannulation are preferred for IO cannulation as follows [<a href="#rid14">14,26</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Manual IO needles</strong> – Examples include the Jamshidi (Baxter Healthcare, McGraw Park, IL) and the modified Dieckmann (Cook Critical Care, Bloomington, IN). Important features include a trocar, a short needle length with a handle that provides a resting place for the palm, and an adjustable flange or depth marking to guide placement. (See <a class="local">'Manual insertion technique'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Battery-powered driver (EZIO) </strong>– The EZIO comes with a <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">lithium</a> powered battery driver and needle sets in three lengths for placement in children and adults. (See <a class="local">'Battery-powered driver'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact-driven devices (Bone injection gun [BIG], FAST1) </strong>– The bone injection gun comes in two sizes that allow IO placement in children and adults. The FAST1 is designed for sternal IO catheter placement in patients ≥12 years of age. (See <a class="local">'Impact-driven devices'</a> below.)</p><p></p><p>Other types of needles may be used if an IO needle or device is not available; these include bone marrow needles, styletted needles, and spinal needles [<a href="#rid49">49,62</a>]. Of these, bone marrow needles are best because they are least likely to bend. Standard hypodermic needles should <strong>not</strong> be used for IO infusion because they often become clogged with bone and bone marrow.</p><p class="headingAnchor" id="H6"><span class="h2">Sites of placement</span><span class="headingEndMark"> — </span>We recommend that all patients who undergo IO placement for life-threatening illness (eg, cardiac arrest) have the first attempt occur at the proximal tibial site, unless otherwise contraindicated. Preferred alternative sites vary based upon the age and skeletal maturity of the patient (<a class="graphic graphic_table graphicRef53119" href="/z/d/graphic/53119.html" rel="external">table 1</a>). A battery-powered or impact driven device is typically required to accomplish IO placement in the proximal tibia of patients six years of age or older. If such a device is not available, then the clinician should attempt manual placement at the medial or lateral malleolus in older patients. (See <a class="local">'Indications'</a> above and <a class="local">'Contraindications'</a> above.)</p><p>In a trial of 183 adults undergoing prehospital vascular access for cardiac arrest, tibial IO placement was significantly more likely to result in successful vascular access when compared to humeral IO or peripheral intravenous (IV) access (91 versus 53 and 41 percent, respectively) [<a href="#rid33">33</a>]. Loss of vascular access during transport was more likely with humeral IO access than either tibial IO or peripheral IV placement. The time to achieve vascular access ranged from five to seven minutes and was similar among the three techniques.</p><p>The primary anatomic locations for IO cannulation are as follows (<a class="graphic graphic_table graphicRef53119" href="/z/d/graphic/53119.html" rel="external">table 1</a>) [<a href="#rid41">41,49</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Proximal tibia </strong>– Prior to placement, extend the leg. Landmarks for proximal tibia placement depend upon age:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Infants and children</strong> – In infants and children, the suggested proximal tibial site is approximately 1 to 2 cm (one finger breadth) below the tibial tuberosity and up to 1 cm medially on the tibial plateau (<a class="graphic graphic_figure graphicRef67266" href="/z/d/graphic/67266.html" rel="external">figure 2</a>). </p><p></p><p class="bulletIndent2">In an analysis of tibial radiographs of 190 children from birth to 16 years of age, a distance of one patient's finger breadth below the tibial tuberosity located a site safely away from the growth plate that also corresponded to a wide medullary cavity diameter and a greater chance of proper IO needle placement when compared with a more distal placement as follows [<a href="#rid63">63</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Infants (&lt;1 year): 0.5 cm</p><p class="bulletIndent3"><span class="glyph">-</span>Child (1 to 13 years): 1 cm</p><p class="bulletIndent3"><span class="glyph">-</span>Young adolescent (14 to &lt;16 years): 1.5 cm</p><p></p><p class="bulletIndent2">This study supports locating IO placement at 1 cm below and medial to the tibial tuberosity for most infants and children up to 13 years of age. Given the variability of the position of the growth plate at any given age in children, we do not advocate an IO placement site closer than 1 cm below the tibial tuberosity. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Skeletally mature adolescents and adults</strong> – In skeletally mature adolescents and adults, the recommended site is 3 cm (two finger breadths) below the inferior tip of the patella and 2 cm medial. The proximal tibial site is rapidly identified and most familiar to emergency clinicians. Furthermore, in patients with cardiac arrest, proximal tibial IO placement avoids interfering with ongoing cardiac compressions. (See <a class="local">'Manual insertion technique'</a> below and <a class="local">'Bone injection gun'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Distal femur </strong>– The distal femur site is in the midline approximately 1 to 2 cm above the superior border of the patella with the leg in extension. This site is an alternative site for manual or device-assisted IO placement in infants and young children in whom the IO needle can traverse the tissues of the distal thigh and still reach the marrow cavity (<a class="graphic graphic_figure graphicRef56412" href="/z/d/graphic/56412.html" rel="external">figure 3</a>). (See <a class="local">'Manual insertion technique'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Distal tibia or fibula </strong>– The malleoli sites are approximately 1 to 2 cm superior to the malleoli in the bone’s axis. The medial malleolus (distal tibia) is preferred to the lateral malleolus (<a class="graphic graphic_figure graphicRef51195" href="/z/d/graphic/51195.html" rel="external">figure 4</a>). These sites are available for manual or device-assisted IO placement in children, adolescents, and adults. (See <a class="local">'Techniques'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Proximal humerus </strong>– The greater tubercle of the proximal humerus is appropriate for IO placement in skeletally mature adolescents and adults. To identify this site, the clinician should adduct and internally rotate the upper arm (hand on abdomen) to make damage to the medial structures of the axillary plexus unlikely. The greater tubercle of the proximal humerus is located approximately 2 cm below the acromion process. Alternatively, it can be directly palpated from below. (<a class="graphic graphic_figure graphicRef57495" href="/z/d/graphic/57495.html" rel="external">figure 5</a>). This site typically requires a battery-powered driver or spring-loaded impact device for successful IO cannulation. (See <a class="local">'Battery-powered driver'</a> below and <a class="local">'Bone injection gun'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Manubrium </strong>– The superior one-third of the sternum may be accessed in adults using a specially designed IO device (FAST1 IO infusion system, PYNG medical, Richmond, British Columbia, Canada) [<a href="#rid64">64</a>]. The device comes with a target patch that is applied along the sternal notch to assist with site identification and placement. (See <a class="local">'FAST1'</a> below.)</p><p></p><p class="headingAnchor" id="H4931995"><span class="h2">Choice of device</span><span class="headingEndMark"> — </span>The choice of device (manual, battery-powered, or impact-driven) varies by age as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Younger than one year of age </strong>– We suggest that, in infants under one year of age, clinicians use manual needles or battery-powered devices for IO insertion rather than an impact-driven device. Observational studies suggest that the success rates for manual placement and battery-powered devices in infants are similar, and both techniques have been shown to be easily learned by a variety of health care providers [<a href="#rid18">18,20,22,23</a>]. Manual IO needles are less expensive and are more widely available than other devices. Time to manual IO placement is longer than for a battery-powered device but shorter than for an impact-driven device.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>One year of age and older</strong> – We suggest that, in children one year of age or older, adolescents, and adults, clinicians use a battery-powered device for IO placement, if available, rather than a manual needle or impact-driven device. Success rates for patients in these age categories appear to be higher with battery-powered IO placement and time to insertion is shorter.</p><p></p><p class="bulletIndent1">Available evidence indicates the following success rates and time to IO insertion in children and adults undergoing resuscitation:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Manual needles: 76 to 100 percent (50 to 67 percent in patients over one year of age) [<a href="#rid31">31,65-67</a>], median time to insertion 38 seconds [<a href="#rid66">66</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Battery-powered driver: 87 to 97 percent [<a href="#rid22">22,23,68</a>], median time to insertion &lt;10 seconds [<a href="#rid23">23</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bone injection gun: 45 to 91 percent [<a href="#rid66">66,69-71</a>], median time to insertion 49 seconds [<a href="#rid66">66</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>FAST1: 72 to 95 percent [<a href="#rid66">66,68,72</a>], median time to insertion 62 seconds [<a href="#rid66">66</a>]</p><p></p><p>Evidence to guide the choice of IO insertion device is limited to observational studies and small trials that vary according to the setting (eg, prehospital, hospital), clinical provider (eg, paramedic, medic, physician), site of insertion, and patient population (pediatric or adult) and do not allow direct comparisons among all devices available. In order to maximize the chance of successful IO cannulation, proper training is essential prior to use, regardless of which IO insertion technique is chosen. (See <a class="local">'Training'</a> above.)</p><p>Suggested sites of IO placement are discussed separately. (See <a class="local">'Sites of placement'</a> above.)</p><p class="headingAnchor" id="H1240422429"><span class="h2">Analgesia</span><span class="headingEndMark"> — </span>In critically ill children and adults who require immediate vascular access (eg, patients in arrest or severe shock), IO placement is performed without analgesia [<a href="#rid73">73</a>]. These patients may receive systemic analgesia (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> intraosseously) or infusion of preservative-free <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>, as described below, if they become responsive to pain once the IO is placed and as tolerated by their clinical condition.</p><p>In awake patients for whom IO placement is in response to difficulty with peripheral venous access and whose condition is not an emergency, we suggest analgesia for IO placement using local infiltration of anesthetic at the IO site and administration of preservative-free <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> through the IO cannula prior to infusion of medications, fluids, or blood products. Infiltration of the periosteum is necessary to achieve analgesia prior to placement (see  <a class="medical medical_review" href="/z/d/html/6324.html" rel="external">"Subcutaneous infiltration of local anesthetics", section on 'Direct infiltration'</a>). In one observational study of 1119 patients from the manufacturer database, the pain of EZ-IO insertion in children and adults was less than the pain during infusion (mean pain score 3.4 versus 5.4, respectively) [<a href="#rid74">74</a>]. Thus, local infiltration of the IO insertion site with local anesthetic may not be necessary in adolescents and adults when using a battery-powered driver.</p><p>If electing to provide analgesia prior to IO infusion, use preservative-free intravenous <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> as follows [<a href="#rid73">73</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The usual initial dose is 0.5 mg/kg <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> (0.025 mL/kg of 2 percent [20 mg/mL] preservative-free lidocaine formulation for intravenous use, maximum dose: 40 mg [2 mL]). Observe recommended cautions and contraindications for administration of intravenous lidocaine. (See  <a class="medical medical_review" href="/z/d/html/86747.html" rel="external">"Major side effects of class I antiarrhythmic drugs", section on 'Lidocaine (intravenous)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For pediatric and adult patients weighing 40 kg or greater, prime the connection tubing with <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>. For the EZ-Connect system, the priming volume is approximately 1.0 mL which corresponds to 20 mg of preservative-free lidocaine 2 percent. After IO placement, attach the tubing to the IO and administer intravenous lidocaine by attaching a syringe containing an additional 20 mg of preservative-free intravenous lidocaine 2 percent. Slowly infuse the lidocaine over two minutes. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For pediatric patients weighing less than 40 kg, administer intravenous <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> after IO placement by carefully attaching the syringe directly to the needle hub. Aspirate the IO needle to remove air and then slowly infuse the intravenous lidocaine by syringe over two minutes. Then connect tubing primed with normal <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> to the IO.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Allow <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> to dwell in the IO space for one minute after slow infusion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Flush the IO with 5 to 10 mL of normal <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a>. Some clinicians prefer to flush once with heparinized saline (10 units/mL in infants &lt;10 kg and 100 units/mL in infants and children 10 kg of weight or greater and in adults although no evidence is available to indicate longer patency of the IO catheter when heparin is given.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The duration of analgesic effect is typically less than one hour [<a href="#rid73">73</a>]. Redosing is accomplished by administering half the initial <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> dose IO over 60 seconds.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Provide systemic pain control (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> intraosseously) to patients with persistent pain during IO infusion despite <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> administration.</p><p></p><p class="headingAnchor" id="H17936377"><span class="h1">TECHNIQUES</span><span class="headingEndMark"> — </span>Intraosseous (IO) needles may be placed manually or with the assistance of specifically designed devices.</p><p class="headingAnchor" id="H7"><span class="h2">Manual insertion technique</span><span class="headingEndMark"> — </span>Manual insertion in the proximal tibia is generally difficult to perform in patients over six years of age. The distal tibial site is preferred in older patients. A high quality video is available in the reference to assist with learning the manual placement technique [<a href="#rid75">75</a>].</p><p>The following step-by-step technique for manual IO cannulation and removal assumes the use of the proximal tibial location (<a class="graphic graphic_figure graphicRef81759" href="/z/d/graphic/81759.html" rel="external">figure 6</a> and <a class="graphic graphic_figure graphicRef67266" href="/z/d/graphic/67266.html" rel="external">figure 2</a>) [<a href="#rid49">49,76</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Placement</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Don a surgical mask, eye protection, and latex-free sterile gloves.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prepare the injection site with an antiseptic (eg, <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">chlorhexidine</a> or <a class="drug drug_general" data-topicid="9801" href="/z/d/drug information/9801.html" rel="external">povidone iodine</a> solution).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If the child is awake, infiltrate the skin, subcutaneous tissue, and periosteum with 1 percent <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Place the leg with knee extended in neutral position and then slightly externally rotate at the hip to expose the flat part of the tibial surface, and externally rotate the foot.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Check the needle to ensure that the bevels of the outer needle and the internal stylet are properly aligned.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grasp the leg distally and lateral to the insertion site with the palm and fingers of the nondominant hand to brace the leg against the force of IO placement and to prevent distal leg movement during the procedure (<a class="graphic graphic_figure graphicRef68441" href="/z/d/graphic/68441.html" rel="external">figure 7</a>). In infants and young children, the nondominant hand may be placed above the site and wrap around the knee and thigh (<a class="graphic graphic_figure graphicRef81759" href="/z/d/graphic/81759.html" rel="external">figure 6</a>). No portion of the stabilizing hand should rest behind the insertion site because this places the operator at risk for needle-stick injury should the IO needle be inadvertently driven completely through the extremity.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Palpate the landmarks to identify the flat surface of the tibia approximately 1 to 2 cm below and slightly (up to 1 cm) medial to the tibial tuberosity, and insert the IO needle through the skin (<a class="graphic graphic_figure graphicRef81759" href="/z/d/graphic/81759.html" rel="external">figure 6</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Direct the IO needle perpendicular to the entry site (<a class="graphic graphic_figure graphicRef68441" href="/z/d/graphic/68441.html" rel="external">figure 7</a> and <a class="graphic graphic_figure graphicRef81759" href="/z/d/graphic/81759.html" rel="external">figure 6</a>) or, in skeletally immature children, at a slight angle (10 to 15 degrees) from vertical (caudad for the proximal tibia (<a class="graphic graphic_figure graphicRef67266" href="/z/d/graphic/67266.html" rel="external">figure 2</a>); cephalad for the distal tibia or femur (<a class="graphic graphic_figure graphicRef51195" href="/z/d/graphic/51195.html" rel="external">figure 4</a> and <a class="graphic graphic_figure graphicRef56412" href="/z/d/graphic/56412.html" rel="external">figure 3</a>)).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Apply pressure with a twisting motion (<a class="graphic graphic_figure graphicRef68441" href="/z/d/graphic/68441.html" rel="external">figure 7</a>). Avoid rocking the needle side to side which may bend it or enlarge the access hole and lead to extravasation of fluid. As the needle passes through the cortex and into the marrow cavity, a "give" or release of resistance is felt. Clinicians not experienced in bone marrow needle insertion should understand that considerable force is needed to introduce the needle into the bone marrow when traditional methods are used (rather than a spring-loaded device or battery-powered driver). A back-and-forth-twisting motion works best to pierce the bony cortex.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unscrew the needle cap and remove the stylet. If the needle has an adjustable flange, carefully screw the flange down to the skin surface while stabilizing the needle.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aspirate bone marrow to identify correct placement of the IO catheter and, if desired, to obtain a sample for laboratory analysis, using a syringe attached directly to the hub or the manufacturer-provided extension set. The provider may not always be able to aspirate bone marrow despite correct IO position in the medullary cavity. (See <a class="local">'Confirmation of placement'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Provide analgesia, as needed and depending upon patient status, by slow administration of 0.5 mg/kg <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> (2 percent [20 mg/mL] preservative-free formulation, maximum dose: 40 mg). (See <a class="local">'Analgesia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Once proper placement is confirmed, flush the needle with 10 mL of normal <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> and connect it to conventional IV tubing. Some clinicians prefer to flush once with heparinized saline (10 units/mL in infants &lt;10 kg and 100 units/mL in infants and children 10 kg of weight or greater and in adults although no evidence is available to indicate longer patency of the IO catheter when heparin is given.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Secure the bone marrow needle with tape and a dressing that does not obscure the needle placement site so that infiltration can be rapidly detected (see <a class="local">'Detection of infiltration'</a> below). IO needles that are properly placed are secure and not easily dislodged.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Removal </strong>– Remove the needle by grasping the shaft and pulling up with a slight rotary motion. Apply pressure to the IO site. Dress the site using aseptic technique.</p><p></p><p class="bulletIndent1">Technical difficulties with manual IO needle placement usually decrease with experience and familiarity with the procedure. Strategies to improve the success rate of IO needle placement include emphasizing rotary motion, stabilizing the tubing and limb, monitoring continuously for extravasation, and using strong, sharp needles [<a href="#rid77">77</a>].</p><p></p><p class="headingAnchor" id="H17936325"><span class="h2">Battery-powered driver</span><span class="headingEndMark"> — </span>Battery-powered IO driver and needle sets are available for use in children and adults (EZ-IO, Teleflex, Morrisville, North Carolina).</p><p>The proper needle length should be modified by the depth of subcutaneous tissue overlying the bone surface. The weight-based manufacturer recommendations for needle length are provided below but should always be tested at the time that the needle is pushed through the skin and subcutaneous tissue to the bone surface and prior to drilling. The provider should ensure that the black line on the needle is still visible above the skin before drilling; otherwise, the needle will be too short to penetrate into the bone marrow cavity.</p><p>The 15-gauge needles come in three lengths as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>15 mm (pink) suggested for placement in patients weighing 3 to 39 kg; however, a 25 mm (blue) needle may be necessary to reach the medullary cavity for children &gt;5 to 10 kg, especially for patients with excessive subcutaneous tissue [<a href="#rid63">63</a>] </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>25 mm (blue) suggested for placement in patients ≥40 kg with normal subcutaneous tissue</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>45 mm (yellow) suggested for placement in patients ≥40 kg with excessive subcutaneous tissue</p><p></p><p>A high-quality video is available in the reference to assist with learning the battery-powered driver technique [<a href="#rid75">75</a>]. The needles may be inserted in the proximal or distal tibia, distal femur in infants and children with limited subcutaneous tissue or, in skeletally mature adolescents and adults, the proximal humerus [<a href="#rid14">14,64,78</a>]. (See <a class="local">'Sites of placement'</a> above.)</p><p>Placement and removal of the EZIO is performed as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Placement</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Identify the placement site based upon anatomic landmarks. (See <a class="local">'Sites of placement'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Don appropriate personal protective equipment and prepare the insertion site as for the manual insertion technique. (See <a class="local">'Manual insertion technique'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ensure that the appropriate needle is selected based upon the patient’s weight and the amount of subcutaneous tissue over the selected insertion site.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Securely seat the needle on the battery-powered driver.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Remove the needle safety cap.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Position the driver with the needle at a 90 degree angle to the bone.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Gently drive or manually press the needle until the tip touches the bone. Ensure that at least 5 mm of the catheter is visible above the skin at this point.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Squeeze the driver trigger and apply light but steady downward pressure to penetrate the bone. Insufficient pressure may result in the needle not penetrating the bone.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Release the trigger to stop insertion when a sudden decrease in resistance is felt ("give" or "pop") or when the appropriate depth, as indicated on the needle, is reached. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Wait for the driver to stop spinning. Then, while holding the catheter in place, remove the driver by pulling straight up from the catheter and unscrew the needle stylet by rotating it counter-clockwise.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aspirate bone marrow to identify correct placement of the IO catheter and, if desired, to obtain a sample for laboratory analysis using a syringe attached directly to the hub or the manufacturer-provided extension set. The provider may not always be able to aspirate bone marrow despite correct IO position in the medullary cavity. (See <a class="local">'Confirmation of placement'</a> below and <a class="local">'Diagnostic studies'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Provide analgesia, as needed and depending upon patient status, by slow administration of 0.5 mg/kg <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> (2 percent [20 mg/mL] preservative-free formulation, maximum dose: 40 mg). (See <a class="local">'Analgesia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Once proper placement is confirmed, secure the needle using tape and gauze or manufacturer supplied fixation dressings (EZ Stabilizer Dressing, VidaCare Corporation, Shavano Park, Texas, United States); ensure that the dressing does not obscure the needle placement site so that infiltration can be rapidly detected. (See <a class="local">'Detection of infiltration'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Flush the needle with 10 mL of normal <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> using the manufacturer supplied IV connector tubing. Some clinicians prefer to flush once with heparinized saline (10 units/mL in infants &lt;10 kg and 100 units/mL in infants and children 10 kg of weight or greater and in adults although no evidence is available to indicate longer patency of the IO catheter when heparin is given.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Removal </strong>– Attach a Luer lock syringe to the catheter hub. While stabilizing the extremity, rotate the catheter and syringe clockwise while pulling straight back. Apply pressure to the IO site. Dress the site using aseptic technique.</p><p></p><p class="headingAnchor" id="H6338311"><span class="h2">Impact-driven devices</span><span class="headingEndMark"> — </span>The impact-driven devices consist of the bone injection gun (BIG, PerSys Medical, Houston, Texas, United States) and the FAST1 (Pyng Medical Corporation, Richmond, British Columbia, Canada).</p><p class="headingAnchor" id="H6337564"><span class="h3">Bone injection gun</span><span class="headingEndMark"> — </span>The spring-loaded bone injection gun is available in sizes and automated insertion depths suitable for patients over 12 years of age (blue casing, 15 gauge needle, insertion depth 2.5 cm) and children from term newborn to 12 years of age (red casing, 18 gauge needle, adjustable insertion depth 0.5 to 1.5 cm) [<a href="#rid14">14,64,79</a>].</p><p>A training video is available in the reference [<a href="#rid79">79</a>].</p><p>IO cannulation of the proximal tibia (all patients) or proximal humerus (skeletally mature adolescents and adults) and removal is accomplished as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Placement</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Identify the placement site based upon anatomic landmarks. (See <a class="local">'Sites of placement'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Don appropriate personal protective equipment and prepare the insertion site as for the manual insertion technique. (See <a class="local">'Manual insertion technique'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Choose the appropriate size bone injection gun (over 12 years of age: adult, term infant to 12 years of age: pediatric). In children, set the insertion depth using the marker located on the device as follows:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>0 to 3 years: 0.5 to 1 cm</p><p class="bulletIndent3"><span class="glyph">-</span>3 to 6 years: 1 to 1.5 cm</p><p class="bulletIndent3"><span class="glyph">-</span>6 to 12 years: 1.5 cm</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Place the device over the insertion site by holding the barrel at a 90 degree angle using the nondominant hand.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Squeeze the sides of the orange safety latch and remove it from the device using the dominant hand. Save the safety latch for later use.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>While firmly holding the device in place with the nondominant hand, use the dominant hand to deploy the needle by grasping under the wings of the device with two fingers and steadily and gently pressing the palm against the top of the device. A "pop" will be heard when the needle is successfully deployed.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Remove the housing of the bone injection gun by pulling upward while rocking it gently from side to side.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Remove the stylet from the cannula.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Place the safety latch around the cannula and tape it down to provide support. The dressing should not obscure the needle placement site so that infiltration can be rapidly detected. (See <a class="local">'Detection of infiltration'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aspirate bone marrow to identify correct placement of the IO catheter and, if desired, to obtain a sample for laboratory analysis using a syringe attached directly to the hub or the manufacturer provided extension set. The provider may not always be able to aspirate bone marrow despite correct IO position in the medullary cavity. (See <a class="local">'Confirmation of placement'</a> below and <a class="local">'Diagnostic studies'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Provide analgesia, as needed and depending upon patient status, by instillation of 0.5 mg/kg <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> (2 percent [20 mg/mL] preservative-free formulation, maximum dose: 40 mg). (See <a class="local">'Analgesia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Once placement is confirmed, flush the IO catheter with 10 to 20 mL of normal <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> through an intravenous catheter connection set. Some clinicians prefer to flush once with heparinized saline (10 units/mL in infants &lt;10 kg and 100 units/mL in infants, children, and adults 10 kg of weight or greater) although no evidence is available to indicate longer patency of the IO catheter when heparin is given.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Removal</strong> – Place the safety latch so that the IO catheter hub is seated in the square notch. If the safety latch is not available, attach a Luer lock syringe. Pull upward with a slight rotary motion. Apply pressure to the IO site. Dress the site using aseptic technique.</p><p></p><p class="headingAnchor" id="H6337732"><span class="h3">FAST1</span><span class="headingEndMark"> — </span>The FAST1 is an impact-driven device designed for placement of an IO catheter (14 gauge and 155 mm in length) at a depth of 6 mm into the manubrium of patients ≥12 years of age through the use of manual pressure [<a href="#rid64">64,80</a>]. </p><p>IO catheter placement and removal in the sternum is performed as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Placement</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Expose the upper sternum and ensure that there is no evidence of trauma to it.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Don appropriate personal protective equipment and prepare the insertion site as for the manual insertion technique using <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">chlorhexidine</a> or iodine and isopropyl alcohol provided in the device package. (See <a class="local">'Manual insertion technique'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Remove the target patch from the package and remove the first backing (labeled "1").</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Identify the sternal notch and place a finger perpendicular to the notch. Apply the patch notches against the finger while maintaining alignment of the patch with the sternal notch.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Remove the bottom half of the backing (labeled "2") and secure the patch to the patient’s sternum and chest.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ensure that the clear "target zone" is centered over the manubrium (upper sternum).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Remove the sharps plug and introducer from the package.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Remove the clear sharps cap from the introducer.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Confirm alignment of the target patch and then, while firmly holding the introducer perpendicular to the manubrium, place the bone probe needles into the circular target zone.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Push down on the introducer steadily while maintaining perpendicular force to the manubrium until the handle separates from the assembly with a "pop."</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Remove the introducer assembly with bone probe needles and use the sharps plug and clear sharps cap to secure the sharps safely.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Remove the blue cap from the IO catheter and connect the infusion tube to the friction connector on the tubing attached to the target patch.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Remove the white cap from the Luer fitting of the target patch infusion tubing.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aspirate bone marrow to identify correct placement of the IO catheter and, if desired, obtain a sample for laboratory analysis. (See <a class="local">'Confirmation of placement'</a> below and <a class="local">'Diagnostic studies'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Provide analgesia, as needed and depending upon patient status, by instillation of 0.5 mg/kg <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> (2 percent [20 mg/mL] preservative-free formulation, maximum dose: 40 mg). (See <a class="local">'Analgesia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Flush the IO catheter with 10 to 20 mL of normal <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> through an intravenous catheter connection set. Some clinicians prefer to flush once with heparinized saline (10 units/mL in infants &lt;10 kg and 100 units/mL in infants, children, and adults 10 kg of weight or greater) although no evidence is available to indicate longer patency of the IO catheter when heparin is given.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Secure the protector dome directly over the target patch.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Removal</strong> – While holding the target patch against the skin, peel away the protector dome. Disconnect the infusion tube. Grasp the infusion tube close to the skin with fingers or a hemostat and pull upwards perpendicular to the manubrium until the infusion tube, including the metal tip is removed from the chest. Remove the target patch and apply pressure to the infusion site. Dress the site using aseptic technique.</p><p></p><p class="headingAnchor" id="H2685868"><span class="h2">Confirmation of placement</span><span class="headingEndMark"> — </span>The following findings indicate correct placement of the IO cannula:</p><p class="bulletIndent1"><span class="glyph">●</span>The needle or catheter stands firmly on its own within the bone.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bone marrow is obtained with aspiration of the needle or catheter, although this may not always occur even with a properly placed IO needle or catheter.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Flushing of the needle or catheter occurs without evidence of extravasation. Resistance to flushing is expected because, unlike a vein, the bone marrow cavity is not distensible.</p><p></p><p>Correct placement in the bone marrow cavity can also be confirmed radiologically using a mini C-arm fluoroscopic imaging device or bedside Doppler ultrasound [<a href="#rid81">81,82</a>]. Doppler ultrasound can also identify incorrect positioning indicated by extravasation of fluid around the IO needle or catheter.</p><p class="headingAnchor" id="H261802902"><span class="h2">Detection of infiltration</span><span class="headingEndMark"> — </span>During infusion of fluids or medications, the provider should frequently check for swelling around the insertion site and, for sites other than the manubrium, swelling posterior to the site (eg, posterior calf in patients with an IO placed in the tibia). Because fluid administration requires the use of a pressure bag or pump, infiltration can occur rapidly during fluid resuscitation. If present, then the IO should be removed and replaced at a site in a different extremity. </p><p class="headingAnchor" id="H17936282"><span class="h1">DURATION OF USE</span><span class="headingEndMark"> — </span>Intraosseous (IO) cannulation provides rapid temporary vascular access. An IO needle should be replaced with a venous line as soon as possible. In one retrospective series describing 58 IO placements in children requiring critical care transport, IO needles were left in place for a mean of 5.2 hours (range 10 minutes to 36 hours) [<a href="#rid65">65</a>]. The only reported complications were local edema and infiltration, occurring in 12 percent of patients. Prolonged IO infusions beyond 24 hours are associated with an increased risk of osteomyelitis [<a href="#rid83">83</a>].</p><p class="headingAnchor" id="H8"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Intraosseous (IO) cannulation is considered to be relatively safe, with a rate of serious complications of less than 1 percent [<a href="#rid5">5,84</a>]. Potential problems include tibial fracture, compartment syndrome, skin necrosis, osteomyelitis, and subcutaneous abscess. Theoretical long-term complications include damage to the bone marrow and disturbance in growth of the bone, as well as fat embolism.</p><p class="bulletIndent1"><span class="glyph">●</span>Bilateral tibial fractures have been described in a single case of a three-month-old infant for whom attempts at IO cannulation using a large bore needle were unsuccessful [<a href="#rid84">84</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infusion of fluids into the subcutaneous tissue has caused compartment syndrome and resulted in amputation of an extremity [<a href="#rid85">85</a>]. Osteomyelitis is a rare complication. A review of the publications describing 4270 IO infusions found only 27 cases (0.6 percent) of osteomyelitis [<a href="#rid83">83</a>]. Most reported infections occurred when the needle remained in place for more than 24 hours. One observational study from 1940 suggested an increased risk of osteomyelitis with infusion of hypertonic fluids, but this association has not been subsequently validated [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No long-term effects on tibial growth were found in a prospective study of 23 children with mean follow-up of 29 months [<a href="#rid86">86</a>]. A smaller study had similar results [<a href="#rid87">87</a>]. Follow-up studies of bone and bone marrow after IO infusions in experimental models also have shown only short-term periostitis and no or minimal long-term sequelae on bone marrow or bone growth [<a href="#rid88">88-90</a>]. The metaphyseal changes after insertion of a bone marrow needle resolve by three weeks [<a href="#rid89">89</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Microscopic fat and bone marrow emboli were found in the pulmonary autopsy specimens of two children who received IO infusion during resuscitation attempts and in 100 percent of study subjects in several animal studies of IO infusion [<a href="#rid60">60,61</a>]. However, the clinical relevance of these emboli is not clear. No significant alterations in arterial oxygenation were noted, nor any intrapulmonary shunting, during a four-hour study period, despite the universal finding of fat and bone marrow emboli [<a href="#rid60">60</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The only reported deaths resulting from IO infusions were associated with the sternal approach using a manual technique. These deaths were from mediastinitis, hydrothorax, and cardiac or great vessel injury [<a href="#rid91">91</a>].</p><p></p><p class="headingAnchor" id="H17936385"><span class="h1">ADDITIONAL RESOURCES</span><span class="headingEndMark"> — </span>Videos are available in the reference to assist with learning techniques for intraosseous cannulation:</p><p class="bulletIndent1"><span class="glyph">●</span>Manual placement [<a href="#rid75">75</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Battery-powered driver technique [<a href="#rid75">75</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Bone injection gun [<a href="#rid79">79</a>]</p><p></p><p class="headingAnchor" id="H2605144104"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/117107.html" rel="external">"Society guideline links: Basic and advanced cardiac life support in children"</a>.)</p><p class="headingAnchor" id="H17936405"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anatomy</strong> – Intraosseous (IO) cannulation provides intravascular access via the medullary sinuses in the bone marrow of long bones (<a class="graphic graphic_figure graphicRef77643" href="/z/d/graphic/77643.html" rel="external">figure 1</a>). These veins, supported by the bony matrix, do not collapse in patients with shock or hypovolemia. (See <a class="local">'Anatomy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications</strong> – We recommend that infants and children in cardiopulmonary arrest or severe shock who do not have readily available intravenous access undergo IO cannulation for medication administration, fluid therapy, and diagnostic studies rather than percutaneous central venous line placement or surgical venous cutdown (<a class="grade" href="https:///uptodate/show/grade_1" rel="external">Grade 1A</a>).</p><p></p><p class="bulletIndent1">For adults in cardiopulmonary arrest or with severe shock in whom peripheral venous access cannot be obtained, we suggest placement of an IO cannula for medication administration, fluid therapy, and diagnostic studies pending percutaneous central venous line placement or surgical venous cutdown (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). We emphasize that an IO needle be flushed before and after medication administration if fluids are not already infusing. (See <a class="local">'Indications'</a> above.)</p><p></p><p class="bulletIndent1">IO cannulation may also be appropriate in patients with emergency conditions in whom reliable venous access cannot be achieved quickly (eg, shock, sepsis, status epilepticus, extensive burns, multiple trauma) or in patients for whom intravascular access is medically necessary and cannot be achieved by other means.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contraindications</strong> – IO cannulation should not be performed in fractured bones, bones with a prior failed IO placement attempt, or in extremities with vascular disruption. IO access also should be avoided in patients with osteogenesis imperfecta, osteopetrosis, right to left congenital cardiac shunts, or those with burns or infection near the access site. (See <a class="local">'Contraindications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Placement site</strong> – We recommend that all patients who undergo IO placement for life-threatening illnesses (eg, cardiac arrest) have the first attempt made at the proximal tibial site, unless otherwise contraindicated (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In infants and children, the suggested proximal tibial site is approximately 1 to 2 cm (one finger breadth) below the tibial tuberosity and up to 1 cm medially on the tibial plateau (<a class="graphic graphic_figure graphicRef67266" href="/z/d/graphic/67266.html" rel="external">figure 2</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In skeletally mature adolescents and adults, the recommended site is 3 cm (two finger breadths) below the inferior tip of the patella and 2 cm medial.</p><p></p><p class="bulletIndent1">Alternative IO placement sites vary based upon the age and skeletal maturity of the patient (<a class="graphic graphic_table graphicRef53119" href="/z/d/graphic/53119.html" rel="external">table 1</a>). A battery-powered or impact driven device is typically required to accomplish IO placement in the proximal tibia of patients &gt;6 years of age. If such a device is not available, the clinician should attempt manual placement at the medial or lateral malleolus. (See <a class="local">'Sites of placement'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Choice of device</strong> – We suggest that, in infants under one year of age, clinicians use manual needles or battery-powered devices for IO insertion rather than an impact-driven device (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Choice of device'</a> above and <a class="local">'Techniques'</a> above.)</p><p></p><p class="bulletIndent1">We suggest that, in children ≥1 year of age, adolescents, and adults, clinicians use a battery-powered device for IO placement, if available, rather than a manual needle or impact-driven device (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). (See <a class="local">'Choice of device'</a> above and <a class="local">'Techniques'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Analgesia</strong> – In critically ill children and adults who require immediate vascular access (eg, patients in arrest or severe shock), IO placement is performed without analgesia. These patients may receive systemic analgesia (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> intraosseously) or infusion of preservative-free <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>, if they become responsive to pain once the IO is placed and as tolerated by their clinical condition. (See <a class="local">'Analgesia'</a> above.)</p><p></p><p class="bulletIndent1">In awake patients for whom IO placement is in response to difficulty with peripheral venous access and whose condition is not an emergency, we suggest analgesia for IO placement be provided by local infiltration of anesthetic at the IO site and administration of preservative-free <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> (0.5 mg/kg preservative-free lidocaine 2 percent [20 mg/mL, maximum dose: 40 mg] given over one minute) through the IO cannula prior to infusion of medications, fluids, or blood products (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Local infiltration of anesthetic at the IO insertion site may not be necessary in adolescents and adults when using a battery-powered driver. (See <a class="local">'Analgesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Techniques</strong> – The technique for manual insertion, battery-powered driver, and impact-driven devices is provided above. Videos are available in the references to assist with learning techniques for manual, battery-powered driver, and bone injection gun IO cannulation. (See <a class="local">'Additional resources'</a> above.)</p><p></p><p class="headingAnchor" id="H1538382661"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Pamela Bailey, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Drinker CK, Drinker KR, Lund CC. The circulation in the mammalian bone marrow. Am J Physiol 1922; 62:1.</a></li><li><a class="nounderline abstract_t">Foëx BA. Discovery of the intraosseous route for fluid administration. J Accid Emerg Med 2000; 17:136.</a></li><li><a class="nounderline abstract_t">Josefson, A. A new method of treatment - intraossal injections. Acta Med Scand 1934; 81:550.</a></li><li><a class="nounderline abstract_t">Tocantins, LM. Rapid absorption of substances injected into the bone marrow. Proc Soc Exp Biol Med 1940; 45:292.</a></li><li><a class="nounderline abstract_t">Tocantins LM, O'Neill JF, Jones HW. Infusions of blood and other fluids via the bone marrow: Application in pediatrics. JAMA 1941; 117:1229.</a></li><li><a class="nounderline abstract_t">HEINILD S, SONDERGAARD T, TUDVAD F. Bone marrow infusion in childhood; experiences from a thousand infusions. J Pediatr 1947; 30:400.</a></li><li><a class="nounderline abstract_t">Valdes MM. Intraosseous fluid administration in emergencies. Lancet 1977; 1:1235.</a></li><li><a class="nounderline abstract_t">Berg RA. Emergency infusion of catecholamines into bone marrow. Am J Dis Child 1984; 138:810.</a></li><li><a class="nounderline abstract_t">Spivey WH, Lathers CM, Malone DR, et al. Comparison of intraosseous, central, and peripheral routes of sodium bicarbonate administration during CPR in pigs. Ann Emerg Med 1985; 14:1135.</a></li><li><a class="nounderline abstract_t">Fiser DH. Intraosseous infusion. N Engl J Med 1990; 322:1579.</a></li><li><a class="nounderline abstract_t">Reades R, Studnek JR, Garrett JS, et al. Comparison of first-attempt success between tibial and humeral intraosseous insertions during out-of-hospital cardiac arrest. Prehosp Emerg Care 2011; 15:278.</a></li><li><a class="nounderline abstract_t">Ngo AS, Oh JJ, Chen Y, et al. Intraosseous vascular access in adults using the EZ-IO in an emergency department. Int J Emerg Med 2009; 2:155.</a></li><li><a class="nounderline abstract_t">Tobias JD, Ross AK. Intraosseous infusions: a review for the anesthesiologist with a focus on pediatric use. Anesth Analg 2010; 110:391.</a></li><li><a class="nounderline abstract_t">Blumberg SM, Gorn M, Crain EF. Intraosseous infusion: a review of methods and novel devices. Pediatr Emerg Care 2008; 24:50.</a></li><li><a class="nounderline abstract_t">McCarthy G, O'Donnell C, O'Brien M. Successful intraosseous infusion in the critically ill patient does not require a medullary cavity. Resuscitation 2003; 56:183.</a></li><li><a class="nounderline abstract_t">Clem M, Tierney P. Intraosseous infusions via the calcaneus. Resuscitation 2004; 62:107.</a></li><li><a class="nounderline abstract_t">Levitan RM, Bortle CD, Snyder TA, et al. Use of a battery-operated needle driver for intraosseous access by novice users: skill acquisition with cadavers. Ann Emerg Med 2009; 54:692.</a></li><li><a class="nounderline abstract_t">Abe KK, Blum GT, Yamamoto LG. Intraosseous is faster and easier than umbilical venous catheterization in newborn emergency vascular access models. Am J Emerg Med 2000; 18:126.</a></li><li><a class="nounderline abstract_t">Jun H, Haruyama AZ, Chang KS, Yamamoto LG. Comparison of a new screw-tipped intraosseous needle versus a standard bone marrow aspiration needle for infusion. Am J Emerg Med 2000; 18:135.</a></li><li><a class="nounderline abstract_t">Anderson TE, Arthur K, Kleinman M, et al. Intraosseous infusion: success of a standardized regional training program for prehospital advanced life support providers. Ann Emerg Med 1994; 23:52.</a></li><li><a class="nounderline abstract_t">Dubick MA, Holcomb JB. A review of intraosseous vascular access: current status and military application. Mil Med 2000; 165:552.</a></li><li><a class="nounderline abstract_t">Cooper BR, Mahoney PF, Hodgetts TJ, Mellor A. Intra-osseous access (EZ-IO) for resuscitation: UK military combat experience. J R Army Med Corps 2007; 153:314.</a></li><li><a class="nounderline abstract_t">Horton MA, Beamer C. Powered intraosseous insertion provides safe and effective vascular access for pediatric emergency patients. Pediatr Emerg Care 2008; 24:347.</a></li><li><a class="nounderline abstract_t">Nadel FM, Lavelle JM, Fein JA, et al. Assessing pediatric senior residents' training in resuscitation: fund of knowledge, technical skills, and perception of confidence. Pediatr Emerg Care 2000; 16:73.</a></li><li><a class="nounderline abstract_t">Itoh T, Lee-Jayaram J, Fang R, et al. Just-in-Time Training for Intraosseous Needle Placement and Defibrillator Use in a Pediatric Emergency Department. Pediatr Emerg Care 2019; 35:712.</a></li><li><a class="nounderline abstract_t">Luck RP, Haines C, Mull CC. Intraosseous access. J Emerg Med 2010; 39:468.</a></li><li><a class="nounderline abstract_t">Kleinman ME, Chameides L, Schexnayder SM, et al. Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S876.</a></li><li><a class="nounderline abstract_t">Neumar RW, Otto CW, Link MS, et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S729.</a></li><li><a class="nounderline abstract_t">Banerjee S, Singhi SC, Singh S, Singh M. The intraosseous route is a suitable alternative to intravenous route for fluid resuscitation in severely dehydrated children. Indian Pediatr 1994; 31:1511.</a></li><li><a class="nounderline abstract_t">Lillis KA, Jaffe DM. Prehospital intravenous access in children. Ann Emerg Med 1992; 21:1430.</a></li><li><a class="nounderline abstract_t">Glaeser PW, Hellmich TR, Szewczuga D, et al. Five-year experience in prehospital intraosseous infusions in children and adults. Ann Emerg Med 1993; 22:1119.</a></li><li><a class="nounderline abstract_t">Fuchs S, LaCovey D, Paris P. A prehospital model of intraosseous infusion. Ann Emerg Med 1991; 20:371.</a></li><li><a class="nounderline abstract_t">Reades R, Studnek JR, Vandeventer S, Garrett J. Intraosseous versus intravenous vascular access during out-of-hospital cardiac arrest: a randomized controlled trial. Ann Emerg Med 2011; 58:509.</a></li><li><a class="nounderline abstract_t">Leidel BA, Kirchhoff C, Braunstein V, et al. Comparison of two intraosseous access devices in adult patients under resuscitation in the emergency department: A prospective, randomized study. Resuscitation 2010; 81:994.</a></li><li><a class="nounderline abstract_t">Leidel BA, Kirchhoff C, Bogner V, et al. Is the intraosseous access route fast and efficacious compared to conventional central venous catheterization in adult patients under resuscitation in the emergency department? A prospective observational pilot study. Patient Saf Surg 2009; 3:24.</a></li><li><a class="nounderline abstract_t">Lee PM, Lee C, Rattner P, et al. Intraosseous versus central venous catheter utilization and performance during inpatient medical emergencies. Crit Care Med 2015; 43:1233.</a></li><li><a class="nounderline abstract_t">McNamara RM, Spivey WH, Unger HD, Malone DR. Emergency applications of intraosseous infusion. J Emerg Med 1987; 5:97.</a></li><li><a class="nounderline abstract_t">de Caen A. Venous access in the critically ill child: when the peripheral intravenous fails! Pediatr Emerg Care 2007; 23:422.</a></li><li><a class="nounderline abstract_t">Glaeser PW, Losek JD. Emergency intraosseous infusions in children. Am J Emerg Med 1986; 4:34.</a></li><li><a class="nounderline abstract_t">Katan BS, Olshaker JS, Dickerson SE. Intraosseous infusion of muscle relaxants. Am J Emerg Med 1988; 6:353.</a></li><li><a class="nounderline abstract_t">Buck ML, Wiggins BS, Sesler JM. Intraosseous drug administration in children and adults during cardiopulmonary resuscitation. Ann Pharmacother 2007; 41:1679.</a></li><li><a class="nounderline abstract_t">Friedman FD. Intraosseous adenosine for the termination of supraventricular tachycardia in an infant. Ann Emerg Med 1996; 28:356.</a></li><li><a class="nounderline abstract_t">Barnard EB, Moy RJ, Kehoe AD, et al. Rapid sequence induction of anaesthesia via the intraosseous route: a prospective observational study. Emerg Med J 2015; 32:449.</a></li><li><a class="nounderline abstract_t">Lewis P, Wright C. Saving the critically injured trauma patient: a retrospective analysis of 1000 uses of intraosseous access. Emerg Med J 2015; 32:463.</a></li><li><a class="nounderline abstract_t">Goodman IS, Lu CJ. Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia. Pediatr Emerg Care 2012; 28:47.</a></li><li><a class="nounderline abstract_t">Orlowski JP, Porembka DT, Gallagher JM, et al. Comparison study of intraosseous, central intravenous, and peripheral intravenous infusions of emergency drugs. Am J Dis Child 1990; 144:112.</a></li><li><a class="nounderline abstract_t">Andersen LW, Holmberg MJ, Granfeldt A, Vallentin MF. Calcium administration and post-cardiac arrest ionized calcium values according to intraosseous or intravenous administration - A post hoc analysis of a randomized trial. Resuscitation 2022; 170:211.</a></li><li><a class="nounderline abstract_t">Cho Y, You Y, Park JS, et al. Comparison of right and left ventricular enhancement times using a microbubble contrast agent between proximal humeral intraosseous access and brachial intravenous access during cardiopulmonary resuscitation in adults. Resuscitation 2018; 129:90.</a></li><li><a class="nounderline abstract_t">Orlowski JP. Emergency alternatives to intravenous access. Intraosseous, intratracheal, sublingual, and other-site drug administration. Pediatr Clin North Am 1994; 41:1183.</a></li><li><a class="nounderline abstract_t">Neufeld JD, Marx JA, Moore EE, Light AI. Comparison of intraosseous, central, and peripheral routes of crystalloid infusion for resuscitation of hemorrhagic shock in a swine model. J Trauma 1993; 34:422.</a></li><li><a class="nounderline abstract_t">Hodge D 3rd. Intraosseous infusions: a review. Pediatr Emerg Care 1985; 1:215.</a></li><li><a class="nounderline abstract_t">Miller L, Kramer GC, Bolleter S. Rescue access made easy. JEMS 2005; 30:suppl 8.</a></li><li><a class="nounderline abstract_t">Ong ME, Chan YH, Oh JJ, Ngo AS. An observational, prospective study comparing tibial and humeral intraosseous access using the EZ-IO. Am J Emerg Med 2009; 27:8.</a></li><li><a class="nounderline abstract_t">Pasley J, Miller CHT, DuBose JJ, et al. Intraosseous infusion rates under high pressure: A cadaveric comparsion of anatomic sites. J Trauma Acute Care Surg 2015; 78:295.</a></li><li><a class="nounderline abstract_t">Grisham J, Hastings C. Bone marrow aspirate as an accessible and reliable source for critical laboratory studies. Ann Emerg Med 1991; 20:1121.</a></li><li><a class="nounderline abstract_t">Ummenhofer W, Frei FJ, Urwyler A, Drewe J. Are laboratory values in bone marrow aspirate predictable for venous blood in paediatric patients? Resuscitation 1994; 27:123.</a></li><li><a class="nounderline abstract_t">Miller LJ, Philbeck TE, Montez D, Spadaccini CJ. A new study of intraosseous blood for laboratory analysis. Arch Pathol Lab Med 2010; 134:1253.</a></li><li><a class="nounderline abstract_t">Brickman KR, Krupp K, Rega P, et al. Typing and screening of blood from intraosseous access. Ann Emerg Med 1992; 21:414.</a></li><li><a class="nounderline abstract_t">Johnson L, Kissoon N, Fiallos M, et al. Use of intraosseous blood to assess blood chemistries and hemoglobin during cardiopulmonary resuscitation with drug infusions. Crit Care Med 1999; 27:1147.</a></li><li><a class="nounderline abstract_t">Orlowski JP, Julius CJ, Petras RE, et al. The safety of intraosseous infusions: risks of fat and bone marrow emboli to the lungs. Ann Emerg Med 1989; 18:1062.</a></li><li><a class="nounderline abstract_t">Fiallos M, Kissoon N, Abdelmoneim T, et al. Fat embolism with the use of intraosseous infusion during cardiopulmonary resuscitation. Am J Med Sci 1997; 314:73.</a></li><li><a class="nounderline abstract_t">Ellemunter H, Simma B, Trawöger R, Maurer H. Intraosseous lines in preterm and full term neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80:F74.</a></li><li><a class="nounderline abstract_t">Capobianco S, Weiss M, Schraner T, et al. Checking the basis of intraosseous access-Radiological study on tibial dimensions in the pediatric population. Paediatr Anaesth 2020; 30:1116.</a></li><li><a class="nounderline abstract_t">Day MW. Intraosseous devices for intravascular access in adult trauma patients. Crit Care Nurse 2011; 31:76.</a></li><li><a class="nounderline abstract_t">Fiorito BA, Mirza F, Doran TM, et al. Intraosseous access in the setting of pediatric critical care transport. Pediatr Crit Care Med 2005; 6:50.</a></li><li><a class="nounderline abstract_t">Hartholt KA, van Lieshout EM, Thies WC, et al. Intraosseous devices: a randomized controlled trial comparing three intraosseous devices. Prehosp Emerg Care 2010; 14:6.</a></li><li><a class="nounderline abstract_t">Seigler RS, Tecklenburg FW, Shealy R. Prehospital intraosseous infusion by emergency medical services personnel: a prospective study. Pediatrics 1989; 84:173.</a></li><li><a class="nounderline abstract_t">Frascone RJ, Jensen JP, Kaye K, Salzman JG. Consecutive field trials using two different intraosseous devices. Prehosp Emerg Care 2007; 11:164.</a></li><li><a class="nounderline abstract_t">David JS, Dubien PY, Capel O, et al. Intraosseous infusion using the bone injection gun in the prehospital setting. Resuscitation 2009; 80:384.</a></li><li><a class="nounderline abstract_t">Schwartz D, Amir L, Dichter R, Figenberg Z. The use of a powered device for intraosseous drug and fluid administration in a national EMS: a 4-year experience. J Trauma 2008; 64:650.</a></li><li><a class="nounderline abstract_t">Gerritse BM, Scheffer GJ, Draaisma JM. Prehospital intraosseus access with the bone injection gun by a helicopter-transported emergency medical team. J Trauma 2009; 66:1739.</a></li><li><a class="nounderline abstract_t">Macnab A, Christenson J, Findlay J, et al. A new system for sternal intraosseous infusion in adults. Prehosp Emerg Care 2000; 4:173.</a></li><li><a class="nounderline abstract_t">Philbeck TE, Miller LJ, Montez D, Puga T. Hurts so good. Easing IO pain and pressure. JEMS 2010; 35:58.</a></li><li><a class="nounderline abstract_t">Fowler RL, Pierce S, Nazeer TE, et al. 1,199 case series: Powered intraosseous insertion provides safe and effectrive vascular access for emergency patients (Abstract). Ann Emerg Med 2008; 52:S152.</a></li><li><a class="nounderline abstract_t">Nagler J, Krauss B. Videos in clinical medicine. Intraosseous catheter placement in children. N Engl J Med 2011; 364:e14.</a></li><li class="breakAll">Ruddy RM. Illustrated techniques of pedatric emergency procedures. In: Textbook of Pediatric Emergency Medicine, 5th ed, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott, Williams, &amp; Wilkins, Philadelphia 2006. p.1880.</li><li><a class="nounderline abstract_t">Simmons CM, Johnson NE, Perkin RM, van Stralen D. Intraosseous extravasation complication reports. Ann Emerg Med 1994; 23:363.</a></li><li class="breakAll">Needle set directions for use. Vidacare, Shavano Park, Texas, USA. http://www.vidacare.com/admin/files/VIDO5-8016-REVH_02-26_HIRES.pdf (Accessed on March 01, 2015).</li><li class="breakAll">Bone injection gun (B. I. G.) educational video links. https://persysmedical.com/wp-content/uploads/2018/03/big-educational-video-links.pdf (Accessed on June 08, 2022).</li><li class="breakAll">Trainer's Manual. FAST1 Intraosseous infusion system. www.pyng.com, June 2010 http://www.pyng.com/wp/wp-content/uploads/FAST1%20Manual%20Jun2010%281%29.pdf (Accessed on April 12, 2011).</li><li><a class="nounderline abstract_t">Garcia CT, Cohen DM. Intraosseous needle: use of the miniature C-arm imaging device to confirm placement. Pediatr Emerg Care 1996; 12:94.</a></li><li><a class="nounderline abstract_t">Tsung JW, Blaivas M, Stone MB. Feasibility of point-of-care colour Doppler ultrasound confirmation of intraosseous needle placement during resuscitation. Resuscitation 2009; 80:665.</a></li><li><a class="nounderline abstract_t">Rosetti VA, Thompson BM, Miller J, et al. Intraosseous infusion: an alternative route of pediatric intravascular access. Ann Emerg Med 1985; 14:885.</a></li><li><a class="nounderline abstract_t">La Fleche FR, Slepin MJ, Vargas J, Milzman DP. Iatrogenic bilateral tibial fractures after intraosseous infusion attempts in a 3-month-old infant. Ann Emerg Med 1989; 18:1099.</a></li><li><a class="nounderline abstract_t">Taylor CC, Clarke NM. Amputation and intraosseous access in infants. BMJ 2011; 342:d2778.</a></li><li><a class="nounderline abstract_t">Claudet I, Baunin C, Laporte-Turpin E, et al. Long-term effects on tibial growth after intraosseous infusion: a prospective, radiographic analysis. Pediatr Emerg Care 2003; 19:397.</a></li><li><a class="nounderline abstract_t">Fiser RT, Walker WM, Seibert JJ, et al. Tibial length following intraosseous infusion: a prospective, radiographic analysis. Pediatr Emerg Care 1997; 13:186.</a></li><li><a class="nounderline abstract_t">Pollack CV Jr, Pender ES, Woodall BN, et al. Long-term local effects of intraosseous infusion on tibial bone marrow in the weanling pig model. Am J Emerg Med 1992; 10:27.</a></li><li><a class="nounderline abstract_t">Woodall BN, Pender ES, Pollack CV Jr, et al. Intraosseous infusion of resuscitative fluids and drugs: long-term effect on linear bone growth in pigs. South Med J 1992; 85:820.</a></li><li><a class="nounderline abstract_t">Brickman KR, Rega P, Schoolfield L, et al. Investigation of bone developmental and histopathologic changes from intraosseous infusion. Ann Emerg Med 1996; 28:430.</a></li><li><a class="nounderline abstract_t">Tocantins LM, O'neill JF. Complications of Intra-Osseous Therapy. Ann Surg 1945; 122:266.</a></li></ol></div><div id="topicVersionRevision">Topic 6321 Version 31.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The circulation in the mammalian bone marrow</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10718241" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Discovery of the intraosseous route for fluid administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : A new method of treatment - intraossal injections</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Rapid absorption of substances injected into the bone marrow</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Infusions of blood and other fluids via the bone marrow: Application in pediatrics</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20290362" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Bone marrow infusion in childhood; experiences from a thousand infusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/68333" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Intraosseous fluid administration in emergencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6475867" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Emergency infusion of catecholamines into bone marrow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2998236" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Comparison of intraosseous, central, and peripheral routes of sodium bicarbonate administration during CPR in pigs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2186277" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Intraosseous infusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21275573" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Comparison of first-attempt success between tibial and humeral intraosseous insertions during out-of-hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20157465" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Intraosseous vascular access in adults using the EZ-IO in an emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19897801" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Intraosseous infusions: a review for the anesthesiologist with a focus on pediatric use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18212613" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Intraosseous infusion: a review of methods and novel devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12589992" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Successful intraosseous infusion in the critically ill patient does not require a medullary cavity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15246590" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Intraosseous infusions via the calcaneus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19643511" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Use of a battery-operated needle driver for intraosseous access by novice users: skill acquisition with cadavers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10750913" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Intraosseous is faster and easier than umbilical venous catheterization in newborn emergency vascular access models.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10750915" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Comparison of a new screw-tipped intraosseous needle versus a standard bone marrow aspiration needle for infusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8273959" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Intraosseous infusion: success of a standardized regional training program for prehospital advanced life support providers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10920658" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A review of intraosseous vascular access: current status and military application.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18619171" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Intra-osseous access (EZ-IO) for resuscitation: UK military combat experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18562874" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Powered intraosseous insertion provides safe and effective vascular access for pediatric emergency patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10784204" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Assessing pediatric senior residents' training in resuscitation: fund of knowledge, technical skills, and perception of confidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29912085" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Just-in-Time Training for Intraosseous Needle Placement and Defibrillator Use in a Pediatric Emergency Department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19545966" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Intraosseous access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20956230" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20956224" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7875811" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The intraosseous route is a suitable alternative to intravenous route for fluid resuscitation in severely dehydrated children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1443836" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Prehospital intravenous access in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8517560" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Five-year experience in prehospital intraosseous infusions in children and adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2003664" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : A prehospital model of intraosseous infusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21856044" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Intraosseous versus intravenous vascular access during out-of-hospital cardiac arrest: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20434823" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Comparison of two intraosseous access devices in adult patients under resuscitation in the emergency department: A prospective, randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19814822" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Is the intraosseous access route fast and efficacious compared to conventional central venous catheterization in adult patients under resuscitation in the emergency department? A prospective observational pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25768683" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Intraosseous versus central venous catheter utilization and performance during inpatient medical emergencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3584924" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Emergency applications of intraosseous infusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17572532" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Venous access in the critically ill child: when the peripheral intravenous fails!</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3004527" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Emergency intraosseous infusions in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3390254" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Intraosseous infusion of muscle relaxants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17698894" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Intraosseous drug administration in children and adults during cardiopulmonary resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8780485" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Intraosseous adenosine for the termination of supraventricular tachycardia in an infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24963149" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Rapid sequence induction of anaesthesia via the intraosseous route: a prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24981009" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Saving the critically injured trauma patient: a retrospective analysis of 1000 uses of intraosseous access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22217885" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1688484" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Comparison study of intraosseous, central intravenous, and peripheral intravenous infusions of emergency drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34929298" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Calcium administration and post-cardiac arrest ionized calcium values according to intraosseous or intravenous administration - A post hoc analysis of a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29928956" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Comparison of right and left ventricular enhancement times using a microbubble contrast agent between proximal humeral intraosseous access and brachial intravenous access during cardiopulmonary resuscitation in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7984381" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Emergency alternatives to intravenous access. Intraosseous, intratracheal, sublingual, and other-site drug administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8483186" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Comparison of intraosseous, central, and peripheral routes of crystalloid infusion for resuscitation of hemorrhagic shock in a swine model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3842171" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Intraosseous infusions: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16382511" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Rescue access made easy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19041528" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : An observational, prospective study comparing tibial and humeral intraosseous access using the EZ-IO.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Intraosseous infusion rates under high pressure: A cadaveric comparsion of anatomic sites</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1928886" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Bone marrow aspirate as an accessible and reliable source for critical laboratory studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8029533" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Are laboratory values in bone marrow aspirate predictable for venous blood in paediatric patients?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20807043" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A new study of intraosseous blood for laboratory analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1554180" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Typing and screening of blood from intraosseous access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10397220" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Use of intraosseous blood to assess blood chemistries and hemoglobin during cardiopulmonary resuscitation with drug infusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2802282" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : The safety of intraosseous infusions: risks of fat and bone marrow emboli to the lungs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9258208" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Fat embolism with the use of intraosseous infusion during cardiopulmonary resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10325819" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Intraosseous lines in preterm and full term neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32720412" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Checking the basis of intraosseous access-Radiological study on tibial dimensions in the pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21459867" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Intraosseous devices for intravascular access in adult trauma patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15636659" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Intraosseous access in the setting of pediatric critical care transport.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19947861" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Intraosseous devices: a randomized controlled trial comparing three intraosseous devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2740168" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Prehospital intraosseous infusion by emergency medical services personnel: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17454802" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Consecutive field trials using two different intraosseous devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19117658" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Intraosseous infusion using the bone injection gun in the prehospital setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18332804" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : The use of a powered device for intraosseous drug and fluid administration in a national EMS: a 4-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19509638" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Prehospital intraosseus access with the bone injection gun by a helicopter-transported emergency medical team.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10782608" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : A new system for sternal intraosseous infusion in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20868946" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Hurts so good. Easing IO pain and pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : 1,199 case series: Powered intraosseous insertion provides safe and effectrive vascular access for emergency patients (Abstract)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21345096" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Videos in clinical medicine. Intraosseous catheter placement in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21345096" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Videos in clinical medicine. Intraosseous catheter placement in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8304621" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Intraosseous extravasation complication reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8304621" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Intraosseous extravasation complication reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8304621" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Intraosseous extravasation complication reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8304621" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Intraosseous extravasation complication reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8859916" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Intraosseous needle: use of the miniature C-arm imaging device to confirm placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19395142" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Feasibility of point-of-care colour Doppler ultrasound confirmation of intraosseous needle placement during resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4025988" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Intraosseous infusion: an alternative route of pediatric intravascular access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2802286" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Iatrogenic bilateral tibial fractures after intraosseous infusion attempts in a 3-month-old infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21622504" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Amputation and intraosseous access in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14676488" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Long-term effects on tibial growth after intraosseous infusion: a prospective, radiographic analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9220503" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Tibial length following intraosseous infusion: a prospective, radiographic analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1736909" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Long-term local effects of intraosseous infusion on tibial bone marrow in the weanling pig model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1323880" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Intraosseous infusion of resuscitative fluids and drugs: long-term effect on linear bone growth in pigs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8839530" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Investigation of bone developmental and histopathologic changes from intraosseous infusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17858653" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Complications of Intra-Osseous Therapy.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
